Cargando…

Structural insight into antibody-mediated antagonism of the Glucagon-like peptide-1 Receptor

The Glucagon-like peptide-1 receptor (GLP-1R) is a member of the class B G protein-coupled receptor (GPCR) family and a well-established target for the treatment of type 2 diabetes. The N-terminal extracellular domain (ECD) of GLP-1R is important for GLP-1 binding and the crystal structure of the GL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hennen, Stephanie, Kodra, János T., Soroka, Vladyslav, Krogh, Berit O., Wu, Xiaoai, Kaastrup, Peter, Ørskov, Cathrine, Rønn, Sif G., Schluckebier, Gerd, Barbateskovic, Silvia, Gandhi, Prafull S., Reedtz-Runge, Steffen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872540/ https://www.ncbi.nlm.nih.gov/pubmed/27196125 http://dx.doi.org/10.1038/srep26236

Ejemplares similares

Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice
por: Galsgaard, Katrine D., et al.
Publicado: (2022)

Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
por: Underwood, Christina Rye, et al.
Publicado: (2010)

Glucagon Receptor Antagonism Ameliorates Progression of Heart Failure
por: Gao, Chen, et al.
Publicado: (2019)

Evaluation of commercially available glucagon receptor antibodies and glucagon receptor expression
por: Bomholt, Anna Billeschou, et al.
Publicado: (2022)

Conformational states of the full-length glucagon receptor
por: Yang, Linlin, et al.
Publicado: (2015)

Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice
por: Wei, Tianjiao, et al.
Publicado: (2023)

Structure of the full-length glucagon class B G protein-coupled receptor
por: Zhang, Haonan, et al.
Publicado: (2017)

Crystallographic characterization of two novel crystal forms of human insulin induced by chaotropic agents and a shift in pH
por: Norrman, Mathias, et al.
Publicado: (2007)

Sustained glucagon receptor antagonism in insulin-deficient high-fat-fed mice
por: Lafferty, Ryan A, et al.
Publicado: (2022)

Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats
por: Karimian, Negar, et al.
Publicado: (2013)

Opposing effects of chronic glucagon receptor agonism and antagonism on amino acids, hepatic gene expression, and alpha cells
por: Elmelund, Emilie, et al.
Publicado: (2022)

Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis
por: Winther-Sørensen, Marie, et al.
Publicado: (2020)

LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome
por: Kaastrup, Katja, et al.
Publicado: (2023)

Somatostatin Receptor Type 2 Antagonism Improves Glucagon and Corticosterone Counterregulatory Responses to Hypoglycemia in Streptozotocin-Induced Diabetic Rats
por: Yue, Jessica T.Y., et al.
Publicado: (2012)

Glucagon Receptor Antagonism Improves Glucose Metabolism and Cardiac Function by Promoting AMP-Mediated Protein Kinase in Diabetic Mice
por: Sharma, Ankit X., et al.
Publicado: (2018)

Glucagon‐like peptide‐1 receptor antagonism impairs basal exercise capacity and vascular adaptation to aerobic exercise training in rats
por: Scalzo, Rebecca L., et al.
Publicado: (2018)

Pharmacological Evaluation of the SCID T Cell Transfer Model of Colitis: As a Model of Crohn's Disease
por: Lindebo Holm, Thomas, et al.
Publicado: (2012)

Glucagon Receptor Signaling and Glucagon Resistance
por: Janah, Lina, et al.
Publicado: (2019)

AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B
por: Johanns, M., et al.
Publicado: (2016)

Induced Human Regulatory T Cells Express the Glucagon-like Peptide-1 Receptor
por: Rode, Anna K. O., et al.
Publicado: (2022)

Metformin Stimulates FGF21 Expression in Primary Hepatocytes
por: Nygaard, Eva B., et al.
Publicado: (2012)

The Impact of Sedentary Lifestyle, High-fat Diet, Tobacco Smoke, and Alcohol Intake on the Hematopoietic Stem Cell Niches
por: Kaastrup, Katja, et al.
Publicado: (2021)

Oral Delivery of Pentameric Glucagon-Like Peptide-1 by Recombinant Lactobacillus in Diabetic Rats
por: Lin, Yin, et al.
Publicado: (2016)

Role of phosphodiesterase and adenylate cyclase isozymes in murine colonic glucagon-like peptide 1 secreting cells
por: Friedlander, Ronn S, et al.
Publicado: (2011)

Stability of glucagon-like peptide 1 and glucagon in human plasma
por: Wewer Albrechtsen, Nicolai J, et al.
Publicado: (2015)

A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor
por: Al-Zamel, Noura, et al.
Publicado: (2019)

Antagonizing T cells
por: LeBrasseur, Nicole
Publicado: (2004)

Antagonism in Diseases
por: Thakkar, K. V.
Publicado: (1932)

Plates and Antagonizers
por: Smith, H. R.
Publicado: (1857)

Physiological Antagonism
por: Johnson, Geo. E.
Publicado: (1896)

Antagonism of Remedies
Publicado: (1880)

The Antagonism of Law
Publicado: (1897)

Glucagon : its role in physiology and clinical medicine
Publicado: (1977)

Pharmacological antagonism of the incretin system protects against diet-induced obesity
por: Svendsen, Berit, et al.
Publicado: (2019)

Therapeutic Upper Gastrointestinal Endoscopy in Pediatric Gastroenterology
por: Schluckebier, Dominique, et al.
Publicado: (2022)

Glucagon‐like peptide‐1 receptor expression in the human eye
por: Hebsgaard, Josephine B., et al.
Publicado: (2018)

Beginning of a new era in glucagon research: Breakthrough by the new glucagon assay
por: Kawamori, Dan
Publicado: (2020)

Revisiting the Pharmacological Value of Glucagon: An Editorial for the Special Issue “The Biology and Pharmacology of Glucagon”
por: Müller, Timo D., et al.
Publicado: (2020)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Quantitative analysis of the CD4(+) T cell response to therapeutic antibodies in healthy donors using a novel T cell:PBMC assay
por: Schultz, Heidi S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fib61s6oh0gla525s3at3skhs6